Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06859424
What this trial is testing

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)+8 more
Center for International Blood and Marrow Transplant Research 358
Testing effectiveness (Phase 2)Study completedNCT03159845
What this trial is testing

Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Stem Cell Transplant Complications
Azienda Ospedaliero, Universitaria Pisana 20
Testing effectiveness (Phase 2)Study completedNCT02985775
What this trial is testing

Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation

Who this might be right for
CMV Infection
Peking University People's Hospital 41
Testing effectiveness (Phase 2)Study completedNCT00644371
What this trial is testing

Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 20
Testing effectiveness (Phase 2)Study completedNCT03925532
What this trial is testing

Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientOsteopeniaOsteoporosis
Roswell Park Cancer Institute 30
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597321
What this trial is testing

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 124
Early research (Phase 1)Study completedNCT01926665
What this trial is testing

Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Large-scale testing (Phase 3)Study completedNCT02406144
What this trial is testing

Trial Studying Maintenance Treatment With Lenalidomide and Dexamethasone Versus Lenalidomide, Dexamethasone and MLN9708 After Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly-diagnosed Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 316
Large-scale testing (Phase 3)Study completedNCT00417911
What this trial is testing

Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients

Who this might be right for
Multiple Myeloma
Nordic Myeloma Study Group 400
Testing effectiveness (Phase 2)Study completedNCT03427866
What this trial is testing

Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.

Who this might be right for
Myelofibrosis
Massachusetts General Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT00675441
What this trial is testing

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Who this might be right for
Graft-versus-Host Disease
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Study completedNCT01101529
What this trial is testing

Treatment of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
NauseaVomiting
Uppsala University Hospital 90
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Large-scale testing (Phase 3)Study completedNCT00002649
What this trial is testing

Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+5 more
National Cancer Institute (NCI) 206
Not applicableStudy completedNCT06267898
What this trial is testing

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML

Who this might be right for
MDSCMML
European Society for Blood and Marrow Transplantation 222
Not applicableNot Yet RecruitingNCT07328724
What this trial is testing

Critical Illness After Hematopoietic Cell Transplantation

Who this might be right for
Critical IllnessVentilated PatientsHematopoetic Stem Cell Transplantation+1 more
Peking University People's Hospital 4,000
Next Page